These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38526324)

  • 21. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JAM3: A prognostic biomarker for bladder cancer via epithelial-mesenchymal transition regulation.
    Pang ZQ; Wang JS; Wang JF; Wang YX; Ji B; Xu YD; He JX; Zhang L; Zhang LQ; Ding BC; Liu Y; Ren MH
    Biomol Biomed; 2024 Feb; 24(4):897-911. PubMed ID: 38400838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
    Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer.
    Shirani N; Mahdi-Esferizi R; Eshraghi Samani R; Tahmasebian S; Yaghoobi H
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2114. PubMed ID: 38886335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying SLC2A6 as the novel protective factor in breast cancer by TP53-related genes affecting M1 macrophage infiltration.
    Dai C; Man Y; Zhang L; Zhang X; Xie C; Wang S; Zhang Y; Guo Q; Zou L; Hong H; Jiang L; Shi Y
    Apoptosis; 2024 Aug; 29(7-8):1211-1231. PubMed ID: 38622369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
    Li H; Tang X; Sun Z; Qu Z; Zou X
    Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
    Gong M; Liu X; Zhao X; Wang H
    BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
    Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
    Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
    Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
    Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis.
    Wang X; Yang F; Sun Z; Zhao G; Pu Q; Geng C; Dong K; Zhang X; Liu Z; Song H
    Mol Carcinog; 2024 Jul; 63(7):1392-1405. PubMed ID: 38651944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.
    Liang G; Ling Y; Mehrpour M; Saw PE; Liu Z; Tan W; Tian Z; Zhong W; Lin W; Luo Q; Lin Q; Li Q; Zhou Y; Hamai A; Codogno P; Li J; Song E; Gong C
    Mol Cancer; 2020 Mar; 19(1):65. PubMed ID: 32213200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
    Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
    Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
    Mo Q; Xu K; Luo C; Zhang Q; Wang L; Ren G
    Biochem Biophys Res Commun; 2021 May; 553():17-24. PubMed ID: 33756341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis.
    Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B
    Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.